E. Ohman J:Or Asset Management Ab Allogene Therapeutics, Inc. Transaction History

E. Ohman J:Or Asset Management Ab

  • $4.03 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Apr 05, 2024
SELL
$18.39 - $54.04 $136,086 - $399,896
-7,400 Closed
0 $0
Q1 2020

Apr 05, 2024
BUY
$18.22 - $28.25 $7,288 - $11,300
400 Added 5.71%
7,400 $144 Million
Q4 2019

Apr 05, 2024
BUY
$24.82 - $31.4 $173,740 - $219,800
7,000 New
7,000 $182 Million

Others Institutions Holding ALLO

# of Institutions
176
Shares Held
132M
Call Options Held
94.3K
Put Options Held
112K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $375M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email